After being recognized, 20 years ago, as the endotheliumderived relaxing factor in the vascular system [1] , nitric oxide (NO) has been subsequently identified as a neurotransmitter, neuro-modulator [2] and a cytotoxic factor in the immune system [3, 4] . Moreover, a number of studies have revealed a role for NO in producing tissue damage, such as ischemia/reperfusion injury [3, 5] or excitatory neuronal death [6] [7] [8] .
NO is produced from the guanidino group of l-arginine in an NADPH-dependent reaction, catalyzed by a family of nitric oxide synthase (NOS) enzymes [9] . Given NO involvement in numerous vital processes, a critical change in its physiological concentration can harm biological systems. For instance, lower than normal NO levels could lead to hypertension [10, 11] , impotence [12, 13] , hyperglycemia, and arteriosclerosis [14, 15] , to cite a few.
However, a direct release of NO doses to biological targets has clinical limitations, due to both its relative short lifetime and high reactivity [16] . In this regard, in situ transport and delivery of NO-releasing sources such as NO-making enzymes (NOSs) represent potential alternatives. In a related aspect, the NOS gene transfer has been already reported as a potential approach to counteract NO deficiency [16] [17] [18] . Even though the NOS gene therapy has some therapeutic benefits, there are several obstacles to advance clinical practice. The foremost concerns of NOS gene therapy are the limitations of currently available vectors, the need of targeted delivery methods, and the relative difficulties to control the in situ NOS expression.
By contrast, the targeted delivery of NOS enzymes is an important approach to explore. In this regard, carrying vectors such as liposomes are effective delivery systems, able to shuttle molecules to sites of action. Once at a cell site, the liposome lipid bilayer can fuse with the cell membrane bilayer, thereby releasing its contents. The advantages of using liposomes carrying target proteins include the stabilization, prevention of denaturation, or proteolysis of the protein. Consequently, the liposome-entrapped NOS could be safely ferried and released to preordered sites that can potentially be targeted using chemical groups on the surface of the liposomes.
One aim of this study is to investigate the effectiveness of the NOS liposomal transport, and to evaluate the protection of NOS native structure and function within the liposomal microenvironment for potential NO delivery to medically significant targets. Issues of targeted delivery to rored the instability in terms of size as described in the previous section. % NOS activity in liposomes. The Griess assay is commonly used to measure NO synthesis from NOS [20, 21] . This assay quantifies the nitrite as the breakdown product of NO [22] . Appropriate controls with blanks containing all components except the NOS enzymes are part of the calibration curve construction process. The assay was used here to determine NOS activity in liposomes in comparison to NOS activity prior to encapsulation. The Griess assay measurements on our NOS-liposome preparations show that the percentage of the activity inside the liposomes is~76 % (n = 3) of the initial NOS activity. This relatively high % activity value demonstrates the retaining of the NOS activity inside the vesicles.
Measurement of Nitric Oxide release from NOS in liposomes. We used our proprietary NO-sensitive electrochemical ruthenium-modified carbon microfiber sensor [23] in order to monitor nitric oxide dynamically released from single NOS-loaded liposomes upon NOS chemical stimulation. Details about the fabrication of the NOsensor are in the included in the experimental section. The NOS-loaded liposomes were incubated with a PBS buffer solution. A micromanipulator attached to the stage of an inverted microscope allowed the positioning of the NO-selective microsensor 10 AE 1 mm above the liposome surface. A potential of + 0.5 V vs. Ag/AgCl was applied to the NO microsensor. Once a steady background current is obtained, an aliquot of 150 mM of NADPH was injected 10 AE 1 mm away from the isolated single liposome surface to stimulate NO release. NO is then measured as an oxidation current on the NO-sensor.
A typical chronoamperometric dose-response curve in the form of a calibration plot for our NO-sensor is shown in Figure 2 .
The amperometric response of the NO microsensor upon subsequent additions of NADPH and blank PBS buffer solution as a control to the NOS-loaded liposomes preparation is illustrated in Figure 3 .
The stimulation of NO synthesis, upon injection of NADPH in the vicinity of a single liposome using micromanipulators on an inverted microscope stage, generated a flux of NO that is released and detected at the nearby NO-sensitive microfiber, in the form of a change in current signal as a function of time ( Figure 3A) . All electrochemical measurements are performed on fresh preparation of liposomes (1-2 days). The sharp drop in current signal after the injection of 45 nmol of NADPH is due to the oxidation of the NO released from a single NOS-carrying liposome, isolated in a dilute liposome preparation. Control experiments with the addition of 10 mL of buffer solution to NOS-liposomes did not give the response observed with NADPH. Also, as shown in Figure 3B , liposomes with NOS treated l-N-nitroarginine methyl ester (l-NAME), a known potent NOS-inhibitor, do not give the typical responses reflecting full activity. Also, injection of NADPH in the bulk of the solution did not yield the typical oxidation peaks observed when the microsensor is placed near NOS-carrying liposomes ( Figure 3C ).
The pulsed nitric oxide concentration profile released from each NOS-loaded liposome peaks at about 19.8 nM. Using a spherical diffusion model, we calculated the amount of NO released from one liposome to be around~3.7 amol. This value remains relatively constant from one NOS-loaded liposome to another as long as the size does not change.
Conclusions. Overall, we show that NOS encapsulation in DSPC liposomes is achieved using the thin-film hydration method in the presence of NOS enzyme in the hydrating solution. A suspension of monodisperse NOS-containing vesicles is prepared using an extrusion process through a 100-nm pore size membrane. Protein assay measurements show that the method as described achieves relatively high encapsulation efficiency of about 40 AE 25 %. Size monitoring using DLS shows excellent stability of NOS-loaded liposomes during storage for at least 15 days, during which the NOS-enzymatic activity is also retained. Measurement of enzymatic activity shows that the percentage of the activity inside the liposomes is 75 % of the initial NOS activity. Electrochemical measurement of NO released from single NOS-loaded liposomes indicates that the amount of NO released from one liposome in the preparation as described is around 3.7 amol. Together, these results show that NOS encapsulation in DSPC liposomes is a viable approach for the delivery of active NOS enzymes to targeted sites. Work is now in progress to investigate the use and efficiency of The recombinant iNOS proteins used in this work were overexpressed in the E. coli strain BL21 (DE3) using a pCWori vector and purified as reported in the literature [25] . The plasmid was a kind gift from Dr. Stuehrs labs (Lerner Research Institute, Cleveland Clinic).
The dry, thin, lipid film was further dried, by flowing dry N 2 gas into the flask and ensure complete evaporation of the organic solvent. An aqueous solution of the iNOS enzyme of 0.45 mM concentration was then used to hydrate the lipid film before dilution with a pH 7.4 buffer solution. In order to eliminate non-encapsulated protein, the liposome suspension was passed through a Ni 2 + column, which traps only the free histidine-tagged iNOS proteins. The fractions containing NOS-carrying liposomes were collected and used for further analysis.
The liposome average diameter and size distribution of the vesicles were determined by the dynamic light scattering (DLS). A 20 mL aliquot of the liposome dispersion was diluted with 1 ml of filtered buffer solution (0.2 mm pore size polycarbonate filters) and measurements were made at 25 8C. The stability of the liposome dispersion upon storage at 4 8C was monitored periodically by DLS.
The Griess assay reagent kit was used with the instruction provided. Briefly, the NADPH-treated 100 mL of sample was incubated with 100 mL of sulfanilamide for 10 minutes in the dark followed by 10-minute reaction with 100 mL N-1-napthylethylenediamine dihydrochloride (NAD) in the dark at room temperature. The absorbance was recorded at 540 nm. A calibration curve was constructed using known concentration series of NO in buffer conditions similar to our liposomal preparations.
The enzyme activity of NOS-carrying liposomes was determined via the detection of NO, released when stimulated by NADPH, with our Ru-PEDOT modified carbon fiber electrode (CFE) NO-sensitive microsensor. All electrochemical measurement of NO synthesis from NOScarying liposomes is performed on freshly prepared NOSliposomes (1-2 days). Experimental details about the NO-sensor are found elsewhere [23] as well as in other reports about other CFE microsensors developed in our labs [26] . Briefly, this NO microsensor was fabricated as follows. A single carbon fiber (7 mm diameter) was mounted on the end of a copper wire using conductive epoxy, then inserted into the glass capillary and sealed. The carbon fiber was cut leaving a protruding portion of about to 3 mm. All potentials reported here are versus a Ag/AgCl reference electrode. A platinum wire was used as the auxiliary electrode. The polymerization of 3,4-ethylenedioxythiophene (EDOT) monomer was done in a three-electrode electrochemical cell, to provide the matrix on which the catalytic ruthenium nanoparticles used in NO sensing are deposited. The ruthenium nanoparticles are then deposited from a RuCl 3 solution in perchloric acid.
